REG1A expression is a prognostic marker in colorectal cancer and associated with peritoneal carcinomatosis

International Journal of Cancer

Volumn 123, Issue 2, 2008, Pages 409-413

  Astrosini, Christian ^a   Roeefzaad, Claudia ^a   Dai, Yi Yang ^a   Dieckgraefe, Brian K ^b   Jöns, Thomas ^c   Kemmner, Wolfgang ^d  

^a Section of Pathology   (Germany)

^b USA   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Colorectal cancer; Peritoneal carcinomatosis; Prognostic factors; REG1A

Indexed keywords

MOLECULAR MARKER; PROTEIN; REGENERATING ISLET DERIVED 1 ALPHA PROTEIN; LITHOSTATHINE; REG1A PROTEIN, HUMAN; TUMOR MARKER;

AGED; ARTICLE; BIOPSY; CARCINOMATOUS PERITONITIS; COLORECTAL ADENOMA; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE MARKER; EARLY DIAGNOSIS; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; MUCOSA; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGENERATING ISLET DERIVED 1 ALPHA GENE; SENSITIVITY AND SPECIFICITY; TUMOR DIAGNOSIS; UPREGULATION; CANCER STAGING; CARCINOMA; COLORECTAL TUMOR; DNA MICROARRAY; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; KAPLAN MEIER METHOD; METABOLISM; METASTASIS; PATHOLOGY; PERITONEUM TUMOR; PREDICTION AND FORECASTING; REPRODUCIBILITY;

CARCINOMA; COLORECTAL NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; KAPLAN-MEIERS ESTIMATE; LITHOSTATHINE; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERITONEAL NEOPLASMS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 44949147974     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23466     Document Type: Article

References (19)

1. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004;96:1420-5.
2. Kahlenberg MS, Sullivan JM, Witmer DD, Petrelli NJ. Molecular prognostics in colorectal cancer. Surg Oncol 2003;12:173-86.
3. Galizia G, Lieto E, Ferraraccio F, Orditura M, De Vita F, Castellano P, Imperatore V, Romano C, Ciardiello F, Agostini B, Pignatelli C. Determination of molecular marker expression can predict clinical outcome in colon carcinomas. Clin Cancer Res 2004;10:3490-9.
4. Terazono K, Yamamoto H, Takasawa S, Shiga K, Yonemura Y, Tochino Y, Okamoto H. A novel gene activated in regenerating islets. J Biol Chem 1988;263:2111-14.
5. Watanabe T, Yonemura Y, Yonekura H, Suzuki Y, Miyashita H, Sugiyama K, Moriizumi S, Unno M, Tanaka O, Kondo H, Bone AJ, Takasawa S, et al. Pancreatic beta-cell replication and amelioration of surgical diabetes by Reg protein. Proc Natl Acad Sci USA 1994;91:3589-92.
6. Gross DJ, Weiss L, Reibstein I, van den Brand J, Okamoto H, Clark A, Slavin S. Amelioration of diabetes in nonobese diabetic mice with advanced disease by linomide-induced immunoregulation combined with Reg protein treatment. Endocrinology 1998;139:2369-74.
7. Zenilman ME, Kim S, Levine BA, Lee C, Steinberg JJ. Ectopic expression of REG protein: a marker of colorectal mucosa at risk for neoplasia. J Gastrointest Surg 1997;1:194-202.
8. Rechreche H, Montalto G, Mallo GV, Vasseur S, Marasa L, Soubeyran P, Dagorn JC, Iovanna JL. PAP, REG Ialpha and REG Ibeta mRNAs are concomitantly up-regulated during human colorectal carcinogenesis. Int J Cancer 1999;81:688-94.
9. Macadam RC, Sarela AI, Farmery SM, Robinson PA, Markham AF, Guillou PJ. Death from early colorectal cancer is predicted by the presence of transcripts of the REG gene family. Br J Cancer 2000;83:188-95.
10. Violette S, Festor E, Pandrea-Vasile I, Mitchell V, Adida C, Dussaulx E, Lacorte JM, Chambaz J, Lacasa M, Lesuffteur T. REG IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas. Int J Cancer 2003;103:185-93.
11. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001;25:402-8.
12. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-7.
13. Gretschel S, Haensch W, Schlag PM, Kemmner W. Clinical relevance of sialyltransferases ST6GAL-I and ST3GAL-III in gastric cancer. Oncology 2003;65:139-45.
14. Dieckgraefe BK, Crimmins DL, Landt V, Houchen C, Anant S, Porche-Sorbet R, Ladenson JH, Expression of the regenerating gene family in inflammatory bowel disease mucosa: REG Ialpha upregulation, processing, and antiapoptotic activity. J Investig Med 2002;50:421-34.
15. Chen LC, Hao CY, Chiu YS, Wong P, Melnick JS, Brotman M, Moretto J, Mendes F, Smith AP, Bennington JL, Moore D, Lee NM. Alteration of gene expression in normal-appearing colon mucosa of APC (min) mice and human cancer patients. Cancer Res 2004;64:3694-700.
16. Bishnupuri KS, Luo Q, Murmu N, Houchen CW, Anant S, Dieckgraefe BK. Reg IV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas. Gastroenterology 2006;130:137-49.
17. Bishnupuri KS, Luo Q, Korzenik JR, Henderson JO, Houchen CW, Anant S, Dieckgraefe BK. Dysregulation of Reg gene expression occurs early in gastrointestinal tumorigenesis and regulates anti-apoptotic genes. Cancer Biol Ther 2006;12:1714-20.
18. Bernards R, Weinberg RA. A progression puzzle. Nature 2002;418:823.
19. Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, Fontaumard E, Brachet A, Caillot JL, Faure JL, Porcheron J, Peix JL, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 2000;88:358-63.